Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Upper Cervical Cord Area as a Biomarker of Conversion to Secondary Progressive Multiple Sclerosis.
Publisher Correction: TGFβ signaling mediates microglial resilience to spatiotemporally restricted myelin degeneration.
[Not Available].
Higher disease reactivation risk in women after fingolimod withdrawal.
Neurobrucellosis: A Narrative Review.
Reverse engineering of motor unit discharge in multiple sclerosis reveals heterogeneity of voluntary motor commands.
Independent associations of fatigue with cognitive function and quality of life in multiple sclerosis: a cross-sectional study.
Ofatumumab therapy modulates the meningeal lymphatic draining function in patients with multiple sclerosis: a pilot study.
Lymphopenia predicts infectious complications after alemtuzumab therapy in multiple sclerosis: Real-world experience from a Brazilian cohort.
Environmental Personal Exposure Clusters to Investigate Multiple Sclerosis and Amyotrophic Lateral Sclerosis Progression.
Game-based and gamification-enhanced telerehabilitation for physical therapy in people with multiple sclerosis: a scoping review.
Assessment of Cortical Myelination in Patients with MS via T1-Weighted/FLAIR Ratio: A Longitudinal Follow-Up Study.
Association between cognitive dysfunction and upper extremity performance in multiple sclerosis: a cross-sectional study : Irish journal of medical science.
[Moxibustion promotes hematoma clearance in rats with intracerebral hemorrhage by up-regulating the expressions of PPARγ/CD36 and M2 phenotype polarization of microglia].
Psychometric properties of the Minnesota manual dexterity test in people with multiple sclerosis.
Suspected HSV vs. demyelinating transverse myelitis in patient on TNF alpha inhibitor: a case report.
Targeting non-apoptotic regulated cell death (RCD) to treat neurodegenerative diseases.
Peripheral TARC (CCL17) Levels Track Widespread Microstructural Vulnerability in Cognitively Unimpaired Older African Americans.
Adherence to risk minimization measures for alemtuzumab use in multiple sclerosis: a drug utilization study in four European countries.
Associations between bullous pemphigoid and comorbidities: A Swedish nationwide cohort study of 5,738 patients.
Impact of genetic polymorphisms in the interleukin-18 and interleukin-21 genes on the risk and clinical outcomes of multiple sclerosis.
Mitochondrial transfer: A comprehensive analysis of mechanistic insights, preclinical applications, and technological innovations.
Ketogenic Diet-Based Therapy for Fatigue in Patients with Multiple Sclerosis.
Glatiramer Acetate Therapy Induces DNA Methylation Changes in Immune Cells of Multiple Sclerosis Patients: A Pilot Study.
Type 1 Diabetes and Multiple Sclerosis Share General Autoimmunity Genetic Variation.
Pages
« first
‹ previous
…
847
848
849
850
851
852
853
854
855
…
next ›
last »